Client NewsOKYO Pharma Limited: Allotment of Ordinary Shares and Total Voting Rights
OKYO Pharma Limited (LSE:OKYO; NASDAQ: OKYO) (the “Company”) today announces that pursuant to an agreement dated 1 February 2023 between the Company and TraDigital Marketing Group, LLC (“TraDigital Marketing”), in consideration for the provision of various consulting services by TraDigital Marketing (the “Services Agreement”), the Company has agreed to allot and issue 2,177,500 ordinary shares of no par value in the capital of the Company (the “Stock Fee Shares”).
OPEN AN ACCOUNT
If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.
Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.